HALO - Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2020 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO)
Q2 2020 Earnings Conference Call
August 10, 2020 4:30 PM ET
Company Participants
Al Kildani – Vice President-Investor Relations and Corporate Communications
Helen Torley – President and Chief Executive Officer
Elaine Sun – Chief Financial Officer
Conference Call Participants
Jim Birchenough – Wells Fargo
Graig Suvannavejh – Goldman Sachs
Ike Oji – BMO
Sean Meakim – Citi
Presentation
Operator
Good afternoon, everyone. I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please go ahead.
Al